Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$4.3 - $9.48 $92,622 - $204,199
21,540 New
21,540 $148,000
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $281,815 - $465,350
-37,228 Reduced 28.51%
93,371 $723,000
Q2 2022

Aug 15, 2022

SELL
$5.04 - $9.48 $692,425 - $1.3 Million
-137,386 Reduced 51.27%
130,599 $998,000
Q1 2022

May 16, 2022

BUY
$7.09 - $89.45 $1.9 Million - $24 Million
267,985 New
267,985 $2.07 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $519M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.